Prevalence of persistent SARS-CoV-2 in a large community surveillance study
Author:
Ghafari MahanORCID, Hall MatthewORCID, Golubchik TanyaORCID, Ayoubkhani Daniel, House ThomasORCID, MacIntyre-Cockett George, Fryer Helen R., Thomson Laura, Nurtay Anel, Kemp Steven A.ORCID, Ferretti LucaORCID, Buck David, Green Angie, Trebes AmyORCID, Piazza Paolo, Lonie Lorne J., Studley Ruth, Rourke Emma, Smith Darren L., Bashton MatthewORCID, Nelson Andrew, Crown MatthewORCID, McCann Clare, Young Gregory R.ORCID, Santos Rui Andre Nunes dosORCID, Richards ZackORCID, Tariq Mohammad Adnan, Cahuantzi Roberto, , , , Barrett JeffORCID, Fraser ChristopheORCID, Bonsall David, Walker Ann Sarah, Lythgoe KatrinaORCID
Abstract
AbstractPersistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks1–5, give rise to highly divergent lineages6–8 and contribute to cases with post-acute COVID-19 sequelae (long COVID)9,10. However, the population prevalence of persistent infections, their viral load kinetics and evolutionary dynamics over the course of infections remain largely unknown. Here, using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ as available evidence suggests that they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Individuals with persistent infection had more than 50% higher odds of self-reporting long COVID than individuals with non-persistent infection. We estimate that 0.1–0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, whereas others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies and/or are commonly found in immunocompromised people11–14. This work has profound implications for understanding and characterizing SARS-CoV-2 infection, epidemiology and evolution.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Dennehy, J. J., Gupta, R. K., Hanage, W. P., Johnson, M. C. & Peacock, T. P. Where is the next SARS-CoV-2 variant of concern? Lancet 399, 1938–1939 (2022). 2. Otto, S. P. et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr. Biol. 31, R918–R929 (2021). 3. Gonzalez-Reiche, A. S. et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat. Commun. 14, 3235 (2023). 4. Hill, V. et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus Evol. 8, veac080 (2022). 5. Ghafari, M., Liu, Q., Dhillon, A., Katzourakis, A. & Weissman, D. B. Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern. Front. Virol. https://doi.org/10.3389/fviro.2022.942555 (2022).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|